Pfizer is prepared and equipped to continue its pandemic sales supremacy, the company’s chief executive said on a July 28 investor call, even if federal contracts for Covid-19 antivirals and vaccines dry up. During the company’s second-quarter earnings call, CEO Albert Bourla stated, in terms of their commercial leadership, they feel Pfizer’s skills are even more […]

The post Pfizer Is Committed To Paxlovid Role In Stalling COVID-19 first appeared on World Pharma Today.